FindTrial
Sign In

mu-Opioid receptor polymorphism & breast cancer expression in Korean adult female population: A retrospective study

mu-Opioid receptor polymorphism & breast cancer expression in Korean adult female population: A retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0001558
Enrollment
416
Registered
2015-07-06
Start date
2015-06-26
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Konkuk University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: patients undergone breast surgery from June 2012 to June 2014 at Konkuk University Medical Centre

Exclusion criteria

Exclusion criteria: 1. age < 19 years 2. history of cancer except breast 3. history of previous radiotherapy or chemotherapy in upper body 4. recurrence after previous breast surgery and metastatic breast cancer from other organ.

Design outcomes

Primary

MeasureTime frame
The pattern of mu-opioid receptor1 gene (OPRM1) A118G polymorphism in benign breast disease and brease cancer—

Secondary

MeasureTime frame
ratio of allele frequency—

Countries

Korea, Republic of

Contacts

Public ContactChung-sik Oh

Konkuk University Medical Center

ohcsik@daum.net+82-2-2030-5454

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026